Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects

Completed · Not applicable · Has a placebo group

Conditions studied: Diabetes Mellitus

In brief

This study's primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II. The secondary objective is to determine the ability of Kombucha to impact blood pressure, and quality of life measures as measured by uniform questionnaire that includes: gut health, colds, infections, headaches, sleep, anxiety (GAD2), depression (PHQ2), skin health.

Key facts

Study ID

NCT04107207

Run by

Georgetown University

People needed

12

Starts

2019-11-11

Expected to finish

2020-07-01

Last updated by the study team

2020-07-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• S/he is above the age of 18
• S/he has the ability to read, speak and write English
• S/he has telephone access
• S/he is diabetic and willing to check blood sugar levels every day
• Hb A1c >7%
• Possesses a glucometer

You may not qualify if…

• Allergy to kombucha ingredients
• Drinks kombucha regularly (>3time per week)

Where it is running

• Georgetown University MedStar Hospital — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.